{"result": "(\"entity\"<|>POLYCYSTIC OVARY SYNDROME<|>EVENT<|>Polycystic Ovary Syndrome (SOP) is a hormonal disorder causing enlarged ovaries with small cysts on the outer edges, often leading to various health issues including infertility and metabolic problems.)\n##\n(\"entity\"<|>HYPERANDROGENISM<|>EVENT<|>Hyperandrogenism is a condition characterized by excessive levels of androgens in the female body, which can lead to symptoms such as hirsutism and irregular menstrual cycles.)\n##\n(\"entity\"<|>TESTOSTERONE<|>EVENT<|>Testosterone is a key androgen hormone that plays a significant role in the development of male characteristics but is also present in females, where it can influence various bodily functions.)\n##\n(\"entity\"<|>DHEA-S<|>EVENT<|>Dehydroepiandrosterone sulfate (DHEA-S) is an androgen produced by the adrenal glands, which can be elevated in conditions like Polycystic Ovary Syndrome.)\n##\n(\"entity\"<|>SHBG<|>EVENT<|>Sex Hormone-Binding Globulin (SHBG) is a protein that binds to sex hormones, including testosterone, and regulates their bioavailability in the body.)\n##\n(\"entity\"<|>OLIGOAMENORRHEA<|>EVENT<|>Oligomenorrhea refers to infrequent menstrual periods, which can be a symptom of hormonal imbalances such as those seen in Polycystic Ovary Syndrome.)\n##\n(\"entity\"<|>AMENORRHEA<|>EVENT<|>Amenorrhea is the absence of menstruation, which can occur due to various hormonal disorders, including Polycystic Ovary Syndrome.)\n##\n(\"entity\"<|>ECOGRAPHY<|>EVENT<|>Ecography, or ultrasound imaging, is a diagnostic tool used to assess the morphology of ovaries, particularly in diagnosing conditions like Polycystic Ovary Syndrome.)\n##\n(\"entity\"<|>HYPERANDROGENISM CLINICAL<|>EVENT<|>Clinical hyperandrogenism is the manifestation of excessive androgens in women, often diagnosed through symptoms like hirsutism.)\n##\n(\"entity\"<|>HIRSUTISM<|>EVENT<|>Hirsutism is a condition characterized by excessive hair growth in women in areas where men typically grow hair, often linked to hormonal imbalances.)\n##\n(\"entity\"<|>FERRIMAN-GALLWEY SCALE<|>EVENT<|>The Ferriman-Gallwey scale is a method used to quantify hirsutism in women, helping to assess the severity of hyperandrogenism.)\n##\n(\"relationship\"<|>POLYCYSTIC OVARY SYNDROME<|>HYPERANDROGENISM<|>Polycystic Ovary Syndrome is often associated with hyperandrogenism, as it is one of the key features of the syndrome<|>8)\n##\n(\"relationship\"<|>HYPERANDROGENISM<|>TESTOSTERONE<|>Hyperandrogenism is characterized by elevated levels of testosterone among other androgens<|>7)\n##\n(\"relationship\"<|>HYPERANDROGENISM<|>DHEA-S<|>DHEA-S can be elevated in women with hyperandrogenism, contributing to the symptoms of conditions like Polycystic Ovary Syndrome<|>6)\n##\n(\"relationship\"<|>TESTOSTERONE<|>SHBG<|>SHBG levels can affect the bioavailability of testosterone in the body, influencing the symptoms of hyperandrogenism<|>5)\n##\n(\"relationship\"<|>OLIGOAMENORRHEA<|>POLYCYSTIC OVARY SYNDROME<|>Oligomenorrhea is one of the diagnostic criteria for Polycystic Ovary Syndrome<|>8)\n##\n(\"relationship\"<|>AMENORRHEA<|>POLYCYSTIC OVARY SYNDROME<|>Amenorrhea can also be a symptom of Polycystic Ovary Syndrome, indicating hormonal imbalance<|>8)\n##\n(\"relationship\"<|>ECOGRAPHY<|>POLYCYSTIC OVARY SYNDROME<|>Ecography is used to diagnose Polycystic Ovary Syndrome by assessing ovarian morphology<|>7)\n##\n(\"relationship\"<|>HYPERANDROGENISM CLINICAL<|>HYPERANDROGENISM<|>Clinical hyperandrogenism is a manifestation of hyperandrogenism, often diagnosed through physical symptoms<|>6)\n##\n(\"relationship\"<|>HYPERANDROGENISM<|>HIRSUTISM<|>Hirsutism is a common symptom of hyperandrogenism, indicating elevated androgen levels<|>7)\n##\n(\"relationship\"<|>HIRSUTISM<|>FERRIMAN-GALLWEY SCALE<|>The Ferriman-Gallwey scale is used to assess the severity of hirsutism in women<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: iperprolactinemia.\n                COLESTEROL                       4A                           4A                                                                   D.  Si se confirma SOP hay que prestar vigilancia a otros factores de riesgo cardiovascular\n                                                                                                                                                       además de su obesidad, como son la intolerancia a la glucosa, la dislipidemia, el hígado\n                                                 E2                                                                                                    graso y el síndrome de apneas del sueño.\n\n\n\n     Figura 2. Síntesis de andrógenos en la mujer.                                                                                                 COMENTARIO\n     Referencias:                                                                                                                                  El diagnóstico de SOP requiere al menos dos de los                      siguientes     criterios de     Rotterdam,\n     • Legro RS. Evaluation and Treatment of Polycystic Ovary Syndrome. En: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext                 en ausencia de otras enfermedades que cursen con hiperandrogenismo o clínica similar:\n       [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK278959/\n       (Updated 2017 Jan 11).                                                                                                                      1.  Hiperandrogenismo clínico o bioquímico. El hirsutismo es la manifestación más fre-\n     • Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH, et al. Evaluation and Treatment of Hirsutism in Premenopausal\n       Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(4):1233-57. https://doi.org/10.1210/                 cuente y es considerado el signo más indicativo de hiperandrogenismo clínico. Se consi-\n       jc.2018-00241                                                                                                                                   dera patológico de forma general en la población femenina un nivel de corte de 8 puntos\n     • Ortiz-Flores AE, Luque-Ramírez M, Escobar-Morreale HF. Síndrome de ovario poliquístico en la mujer adulta. Med Clin (Barc) [Internet].\n       2019;152(11):450-7.                                                                                                                             en la escala de Ferriman-Gall-wey modificada, y específicamente para la población es-\n                                                                                                                                                       pañola, de 10. El andrógeno de mayor potencia, interés y utilidad para definir el hiperan-\n                                                                                                                                                       drogenismo bioquímico sería la testosterona libre, pero su determinación no siempre\n                                                                                                                                                       está disponible      ni tiene   la necesaria fiabilidad, por lo         que se    acepta la determinación\n                                                                                                                                                       de la testosterona total como principal determinación, corrigiéndola para las cifras de\n                                                                                                                                                       SHBG (índice androgénico libre = testosterona total × 100/SHBG). Es frecuente que se\n                                                                                                                                                       encuentren también aumentados otros andrógenos (DHEA-S y 4A).\n                                                                                                                                                   2.  Anovulación. La disfunción ovulatoria en pacientes en edad fértil viene definida por oli-\n                                                                                                                                                       gomenorrea (menos de 8 periodos menstruales en un año) o amenorrea (falta de perio-\n                                                                                                                                                       dos menstruales durante más de 3 meses en ausencia de embarazo), pudiendo también\n                                                                                                                                                       incluirse ciclos mayores de 35 días, polimenorrea (ciclos de menos de 21 días) o situa-\n                                                                                                                                                       ciones de anovulación con reglas normales.\n                                                                                                                                                   3. Morfología de ovario poliquístico en ecografía. La ecografía ovárica debe recoger\n                                                                                                                                                       los detalles necesarios para determinar la morfología característica del SOP, que\n\n\n\n338                                                                                                                                                                                                                                                                       339\n---\n                                                                                                                                                                              GÓNADAS,               SÍNDROME POLIGLANDULAR                                                 6\n                                                                                                                                                                                                  AUTOINMUNE Y MISCELÁNEA\n\n\n\n        son 12 o más folículos en cada ovario de 2 a 9 mm y/o aumento de volumen ovárico                                                       6.6 Transexuales\n        mayor de 10 ml.\n     Mediante la anamnesis y otras pruebas complementarias debe demostrarse                                 a priori   la\n     ausencia de otras enfermedades que cursen con hiperandrogenismo o clínica similar al                                                        20     En un hombre adulto transexual (de mujer a hombre) en tratamiento con\n     ovario poliquístico, como la oligoamenorrea, el uso de medicamentos androgenizantes,                                                               undecanoato de testosterona (1 g por vía i.m. cada 12 semanas), uno de los\n     la determinación       de  17-OH-progesterona, el         cortisol   libre urinario    (CLU) o    salival,  la pro-                                siguientes diagnósticos no tiene implicaciones sobre la decisión de interrumpir\n     lactina o las hormonas tiroideas. Ante un hiperandrogenismo grave, de rápida evolu-                                                                el tratamiento:\n     ción, o   con   niveles de testosterona plasmática total mayores                  de  2 ng/ml     (o de 1 ng/ml\n     en posmen\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}